AI Summary

Researchers at the University of Ottawa Faculty of Medicine report that small extracellular vesicles (sEVs)—ultra‑tiny, bubble‑like structures that naturally transport RNA and other molecules between cells—show promise as precise delivery vehicles for RNA and gene‑editing therapies. They highlight that current drug development aims to move from disease management to correction, but targeting hard‑to‑reach organs such as the brain and kidneys remains a major hurdle. The team’s findings provide compelling evidence that these evolution‑refined metabolic messengers could overcome delivery challenges for gene‑based treatments.

AI summaries can be wrong sometimes—always verify important details using the source article.